<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01610843</url>
  </required_header>
  <id_info>
    <org_study_id>200907757</org_study_id>
    <secondary_id>5UL1RR024979</secondary_id>
    <nct_id>NCT01610843</nct_id>
  </id_info>
  <brief_title>Worldwide Sarcoidosis Research Study</brief_title>
  <acronym>WISE</acronym>
  <official_title>Worldwide Sarcoidosis Research Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect information about the clinical course and characteristics
      of sarcoidosis patients around the world through web-based surveys. Recruitment is directed
      at and driven by patients in the sarcoidosis community. This will allow the the investigators
      to study sarcoidosis patients across all demographic, geographic, and socioeconomic
      boundaries, not just patients seen at large research centers. The investigators believe this
      study can give investigators a broader and less biased view of sarcoidosis. The investigators
      would also like to collect genetic samples on this population to assess genetic variance in
      different phenotypes.

      The information for the study would be provided through a web based survey system that can be
      accessed by patients or physicians of patients from any computer with Internet access. This
      system would collect clinical information in sufficient detail so that the phenotype of
      individual patients can be evaluated. Upon agreeing to participate in further research
      studies through the website, subjects will also have the opportunity to provide a DNA sample.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Define and characterize sarcoidosis phenotypes and methods of care</measure>
    <time_frame>Anticipated by 2017</time_frame>
    <description>To give a broader and less biased view of sarcoidosis</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Sarcoidosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>Longitudinal surveys</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva samples will be collected and processed at the University of Iowa.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals diagnosed with sarcoidosis who have a computer with Internet access.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Sarcoidosis

          -  Access to a computer with Internet

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia K Gerke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alicia K Gerke, MD</last_name>
    <phone>319-356-1869</phone>
    <email>alicia-gerke@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emily K Phillips, BSN</last_name>
    <phone>319-356-1869</phone>
    <email>emily-phillips@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia K Gerke, MD</last_name>
      <phone>319-356-1869</phone>
      <email>alicia-gerke@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Alicia K Gerke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sarcoidstudy.org</url>
    <description>Worldwide Sarcoidosis Research Study</description>
  </link>
  <reference>
    <citation>Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999 Aug;160(2):736-55. Review.</citation>
    <PMID>10430755</PMID>
  </reference>
  <reference>
    <citation>Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885-9.</citation>
    <PMID>11734441</PMID>
  </reference>
  <reference>
    <citation>Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughman RP, Teirstein AS; ACCESS Research Group. The diagnostic pathway to sarcoidosis. Chest. 2003 Feb;123(2):406-12.</citation>
    <PMID>12576358</PMID>
  </reference>
  <reference>
    <citation>Yeager H, Rossman MD, Baughman RP, Teirstein AS, Judson MA, Rabin DL, Iannuzzi MC, Rose C, Bresnitz EA, DePalo L, Hunninghakes G, Johns CJ, McLennan G, Moller DR, Newman LS, Rybicki B, Weinberger SE, Wilkins PC, Cherniack R; ACCESS Research Group. Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Jun;22(2):147-53.</citation>
    <PMID>16053031</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997 Feb 1;145(3):234-41. Review.</citation>
    <PMID>9012596</PMID>
  </reference>
  <reference>
    <citation>Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, Yeager H Jr, McLennan G, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki BA, Weinberger SE, Knatterud GL, Cherniak R; ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis. 2003 Oct;20(3):204-11.</citation>
    <PMID>14620163</PMID>
  </reference>
  <reference>
    <citation>Aranda A, PÃ¡ramo JA, Rocha E. Fibrinolytic activity in plasma after gynecological and urological surgery. Haemostasis. 1988;18(2):129-34.</citation>
    <PMID>3137141</PMID>
  </reference>
  <reference>
    <citation>Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, Knatterud GL, Yeager H Jr, Rose C, Steimel J. Sarcoidosis: social predictors of severity at presentation. Eur Respir J. 2004 Oct;24(4):601-8.</citation>
    <PMID>15459139</PMID>
  </reference>
  <reference>
    <citation>Clark RE, McKnight RC, Kissane JM, Weldon CS. Experimentally reversed pulmonary blood flow. Implications for the surgical management of complex forms of congenital heart disease. Ann Thorac Surg. 1975 Oct;20(4):433-45.</citation>
    <PMID>1180597</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2012</study_first_submitted>
  <study_first_submitted_qc>June 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2012</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Alicia Gerke</investigator_full_name>
    <investigator_title>Assistant Professor; Division of Pulmonary, Critial Care and Occupational Medicine</investigator_title>
  </responsible_party>
  <keyword>Sarcoidosis</keyword>
  <keyword>WISE</keyword>
  <keyword>Sarcoid Study</keyword>
  <keyword>Worldwide Sarcoidosis Research Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

